Table 1.
Study | Study design | Patients | Experimental strategy | Control strategy | Sample size | Outcomes | |
---|---|---|---|---|---|---|---|
Helmet | Control | ||||||
Antonelli 2002 [14] | Prospective pilot case control | Patients with hypoxemic ARF without COPD | Helmet PSV | Facial mask PSV | 33 | 66 | Gas exchange, respiratory rate, intubation rate, length of NIV, level of pressure support, ICU stay and hospital mortality, complications |
Pisani 2015 [15] | Multicenter RCT | AECOPD with hypercapnic ARF | Helmet PSV | Oronasal mask PSV | 39 | 41 | Respiratory rate, dysponea score, intubation rate, level of pressure support, hemodynamics, complications |
Brambilla 2014 [16] | Multicenter RCT | Pneumonia with hypoxemic ARF | Helmet CPAP | Venturi mask Oxygen therapy | 40 | 41 | Gas exchangea, intubation rate, hospital stay and mortality, complications |
Principi 2004 [17] | Historical case control | Hematological malignancy with hypoxemic ARF | Helmet CPAP | Facial mask CPAP | 17 | 17 | Gas exchange, intubation rate, PTS, length of NIV, complications |
Antonelli 2004 [20] | Historical case control | AECOPD with hypercapnic ARF | Helmet PSV | Facial mask PSV | 33 | 33 | Gas exchange, respiratory rate, intubation rate, length of NIV, level of pressure support, hemodynamics, ICU stay, ICU and hospital mortality, complications |
Ali 2011 [29] | RCT | AECOPD with hypercapnic ARF | Helmet PSV | Facial mask PSV | 15 | 15 | Gas exchange, respiratory rate, hemodynamics, ICU stay, PTS, intubation rate, complications |
Özlem 2015 [30] | RCT | AECOPD with hypercapnic ARF | Helmet PSV | Facial mask PSV | 25 | 23 | Gas exchangea, respiratory rateb, PTS, complications, ICU stayb, length of NIV, hospital mortality |
Antonaglia 2011 [31] | RCT | AECOPD with hypercapnic ARF | Helmet PSV | Facial mask PSV | 20 | 20 | Gas exchange, respiratory rateb, intolerance to the interface, length of ICU stayb, time of ventilator assistance |
Patel 2016 [32] | RCT | ARF due to ARDS | Helmet PSV | Facial mask PSV | 44 | 39 | Respiratory rateb, intubation rate, length of NIV, level of pressure support, ICU and hospital stayb, hospital and 90d mortality, complications, ventilator-free days |
Tonnelier 2003 [33] | Historical case control | Cardiogenic pulmonary edema with hypoxemic ARF | Helmet CPAP | Facial mask CPAP | 11 | 11 | Glasgow coma scale, gas exchange, respiratory rate, complications, hospital mortality |
Rocco 2004 [34] | Historical case control | Immunocompromised with hypoxemic ARF | Helmet PSV | Facial mask PSV | 19 | 19 | Gas exchange, respiratory rate, intubation rate, length of NIV, level of pressure support, ICU stay, ICU and hospital mortality, complications |
ARF acute respiratory failure, COPD chronic obstructive pulmonary disease, PSV pressure support ventilation, NIV noninvasive ventilation, ICU intensive care unit, AECOPD exacerbation of COPD, CPAP continuous positive airway pressure, PTS patient tolerance scale, RCT randomized control trail, ARDS acute respiratory distress syndrome
aOutcome presented in figure form
bOutcome presented as interquartile range